Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Novel Pig Model Closely Mimics Human Helicobacter pylori Infection

By BiotechDaily International staff writers
Posted on 08 Oct 2013
Image: Similar anatomical properties between the stomach of humans and pigs may facilitate study of H. pylori-associated disease. Virginia Tech researchers have demonstrated that H. pylori (arrow) is found in the inner lining of the stomach and near aggregates of immune cells. The picture insert shows the typically spindle-shaped H. pylori magnified 1,000 times (Photo courtesy of Virginia Tech).
Image: Similar anatomical properties between the stomach of humans and pigs may facilitate study of H. pylori-associated disease. Virginia Tech researchers have demonstrated that H. pylori (arrow) is found in the inner lining of the stomach and near aggregates of immune cells. The picture insert shows the typically spindle-shaped H. pylori magnified 1,000 times (Photo courtesy of Virginia Tech).
Researchers have developed a novel pig model of Helicobacter pylori infection that closely mimics human gastric pathology and presents an avenue for studying human effector and regulatory responses toward H. pylori.

H. pylori are helix-shaped, Gram-negative bacteria, about three micrometers long with a diameter of about 0.5 micrometers. They are microaerophilic, requiring oxygen but at a lower concentration than is found in the atmosphere. H. pylori contain a hydrogenase, which can be used to obtain energy by oxidizing molecular hydrogen produced by intestinal bacteria. While more than 50% of the world's population harbor H. pylori in their upper gastrointestinal tract, over 80% of people infected with H. pylori show no symptoms. Acute infection may appear as an acute gastritis with abdominal pain or nausea. Where this develops into chronic gastritis, the symptoms, if present, are often those of non-ulcer dyspepsia: stomach pains, nausea, bloating, belching, and sometimes vomiting or black stool. Individuals infected with H. pylori have a 10% to 20% lifetime risk of developing peptic ulcers and a 1% to 2% risk of acquiring stomach cancer.

Small animals such as mice and gerbils have been used as models for H. pylori infection. However, the immune response generated by these animals was found to differ significantly from that of humans. In a paper published in the October 2013 issue of the journal Infection and Immunity investigators at Virginia Tech (Blacksburg, VA, USA) described a novel pig model for studying H. pylori infection.

Similar to the situation in humans, when pigs were infected with H. pylori, the animals generated an increase in pro-inflammatory CD4+ T helper cells, followed by an increase in CD8+ cytotoxic T cells. Marked rises were found in the levels of mRNA needed by peripheral blood mononuclear cells (PBMCs) for the production of inflammatory proteins such as gamma interferon, perforin, and granzyme.

“Pigs have greater anatomic, physiologic, and immunologic similarities to humans than mice, the main animal model used in biomedical research,” said senior author Dr. Raquel Hontecillas, assistant professor of immunology at Virginia Tech. “The results from our new pig model closely mimic what has been reported in clinical settings, which will allow us to comprehensively and systematically investigate human immune responses to H. pylori.”

Related Links:
Virginia Tech


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: To adhere to catheters and start urinary tract infections, bacteria extend microscopic fibers with sticky proteins at their ends. Researchers have developed a vaccine that blocks the EbpA protein, visible as a white bulge above, and stops infections in mice (Photo courtesy of Dr. John Heuser, Washington University School of Medicine).

Blocking Binding of Bacteria to Fibrinogen Prevents Biofilm Formation and Catheter-Associated Bladder Infection in Mice

A team of molecular microbiologists has identified and targeted a critical step in biofilm formation and developed a vaccine that prevents catheter-associated urinary tract infections in mice.... Read more

Drug Discovery

view channel
Image: S-649266 has more robust antibacterial activity than established antibiotics against multidrug-resistant bacteria (Photo courtesy of Shionogi).

Novel Antibiotic Shows Potential for Broad Range of Infections

The emergence of bacterial resistance to known antibacterial agents is becoming a major challenge in treating the infection caused by multi drug resistant (MDR) bacteria. In order to treat bacterial... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.